Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.
about
Aspirin enhances the cytotoxic activity of bortezomib against myeloma cells via suppression of Bcl-2, survivin and phosphorylation of AKT.Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells.Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?
P2860
Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Examining the impact of regula ...... vival in stage 2 colon cancer.
@en
type
label
Examining the impact of regula ...... vival in stage 2 colon cancer.
@en
prefLabel
Examining the impact of regula ...... vival in stage 2 colon cancer.
@en
P2093
P2860
P356
P1476
Examining the impact of regula ...... vival in stage 2 colon cancer.
@en
P2093
Belinda Lee
Caitlin Murphy
Hui-Li Wong
Iain Skinner
Jeanne Tie
Mathu Sinnathamby
Michael Christie
Natalie Turner
Paul Waring
P2860
P356
10.1111/IMJ.13312
P50
P577
2016-11-01T00:00:00Z